Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease

Our data suggest a new mechanism of platelet activation which has the potential to increase risk for thromboembolism in patients with active CD which might be due to platelets poised for thrombin-inducible activation.